Breaking: Salesforce.com (NYSE:CRM) Buy Rating Reconfirmed by Analysts at Oppenheimer Today; The Target is Set to $180.0000

Investors sentiment increased to 1.61 in Q2 2018. Its up 0.17, from 1.44 in 2018Q1. It is positive, as 40 investors sold salesforce.com, inc. shares while 254 reduced holdings. 121 funds opened positi...

from crm - BingNews https://ift.tt/2G2SClY
December 01, 2018 at 10:51PM